X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (165) 165
humans (132) 132
invasive candidiasis (69) 69
infectious diseases (66) 66
antifungal agents (62) 62
antifungal agents - therapeutic use (55) 55
mycoses (54) 54
microbiology (53) 53
health aspects (50) 50
antifungal agents - pharmacology (48) 48
epidemiology (44) 44
invasive fungal-infections (42) 42
microbial sensitivity tests (40) 40
male (39) 39
female (37) 37
fluconazole (36) 36
pharmacology & pharmacy (34) 34
candida - drug effects (33) 33
mortality (33) 33
mycology (33) 33
risk factors (33) 33
drug resistance (32) 32
fungi (32) 32
middle aged (32) 32
blood-stream infections (30) 30
candida (30) 30
amphotericin-b (29) 29
drug resistance in microorganisms (29) 29
fungal infections (29) 29
research (29) 29
candida - isolation & purification (27) 27
infection (27) 27
risk-factors (27) 27
aged (26) 26
animals (26) 26
candidiasis (26) 26
immunology (26) 26
infections (26) 26
candidemia (25) 25
candidiasis - microbiology (24) 24
caspofungin (24) 24
adult (23) 23
voriconazole (23) 23
analysis (22) 22
drug resistance, fungal (22) 22
candidiasis - drug therapy (21) 21
intensive-care-unit (21) 21
liposomal amphotericin-b (21) 21
medicine (21) 21
medicine & public health (21) 21
research article (21) 21
care and treatment (20) 20
echinocandins (20) 20
patients (20) 20
amphotericin b (19) 19
mycoses - drug therapy (19) 19
antifungal susceptibility (18) 18
diagnosis (18) 18
fungicides (18) 18
critically-ill patients (17) 17
drug therapy (17) 17
hematology (17) 17
pediatrics (17) 17
antifungal resistance (16) 16
clinical-practice guidelines (16) 16
fungal-infections (16) 16
invasive pulmonary aspergillosis (16) 16
medical research (16) 16
pneumonia (16) 16
review (16) 16
science (16) 16
sepsis (16) 16
cancer (15) 15
critical care medicine (15) 15
hospitals (15) 15
invasive aspergillosis (15) 15
multidisciplinary sciences (15) 15
candida-albicans (14) 14
colonization (14) 14
dermatology (14) 14
echinocandins - pharmacology (14) 14
micafungin (14) 14
neutropenia (14) 14
transplantation (14) 14
aspergillus-fumigatus (13) 13
bacteria (13) 13
echinocandin resistance (13) 13
echinocandins - therapeutic use (13) 13
immunocompromised host (13) 13
invasive fungal infection (13) 13
medicine, experimental (13) 13
nosocomial infections (13) 13
yeast (13) 13
aged, 80 and over (12) 12
aspergillosis (12) 12
bacterial infections and mycoses (12) 12
bacterial pneumonia (12) 12
candidiasis, invasive - drug therapy (12) 12
children (12) 12
identification (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 2, pp. 134 - 140
BACKGROUND: Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from... 
Amphotericin b resistance | Candida auris | Fluconazole resistance | Candidemia | Whole genome sequence typing | INFECTIOUS DISEASES | CLONAL STRAIN | ERG11 | MICROBIOLOGY | ANTIFUNGAL SUSCEPTIBILITY | IMMUNOLOGY | IDENTIFICATION | candidemia | amphotericin B resistance | fluconazole resistance | whole genome sequence typing | FLIGHT MASS-SPECTROMETRY | DESORPTION IONIZATION-TIME | SURVEILLANCE | ALBICANS | INDIA | INVASIVE CANDIDIASIS | Drug Resistance, Multiple | Humans | Middle Aged | Candidiasis - epidemiology | Child, Preschool | Infant | Male | Phylogeny | Candidiasis - microbiology | Microbial Sensitivity Tests | Young Adult | Candida - classification | Genome, Fungal | Adult | Female | Child | Drug Resistance, Fungal | Infant, Newborn | Antifungal Agents - pharmacology | Candida - genetics | Candidemia - microbiology | DNA, Ribosomal Spacer | Global Health | Candidemia - epidemiology | Candida - isolation & purification | Whole Genome Sequencing | Candidiasis - etiology | Adolescent | Cytochrome P-450 Enzyme System - genetics | Aged | Polymorphism, Single Nucleotide | Candida - drug effects | Mutation | RNA, Ribosomal, 28S - genetics | Research | Nucleotide sequencing | Drug resistance | Patients | Health aspects | DNA sequencing | Fungi | Multidrug resistant organisms | Genomes | Yeast | Fungal infections | Epidemiology | Index Medicus | Major
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Drug Delivery Science and Technology, ISSN 1773-2247, 08/2017, Volume 40, pp. 59 - 65
This study investigated the chemical and morphological structure of solid lipid nanoparticles made from copaiba oil. Moreover, the influence of allantoin in... 
Multidrug-resistant yeast | Copaiba oil | Antifungal activity | Allantoin | Solid lipid nanoparticles | Candida parapsilosis | DIPTERA | EFFICACY | OLEORESIN | MECHANISMS | AMPHOTERICIN-B | COPAIFERA SP | PHARMACOLOGY & PHARMACY | DERMATOPHYTES | INVASIVE CANDIDIASIS
Journal Article
DRUGS, ISSN 0012-6667, 2012, Volume 72, Issue 6, pp. E17 - E32
Intra-abdominal infection (IAI) is a complex disease entity in which different aspects must be balanced in order to select the proper antimicrobial regimen and... 
ABDOMINAL SEPSIS | RISK-FACTORS | INTENSIVE-CARE-UNIT | MULTIDRUG-RESISTANT BACTERIA | ESCHERICHIA-COLI | BETA-LACTAM ANTIBIOTICS | PHARMACOLOGY & PHARMACY | POSTOPERATIVE PERITONITIS | TOXICOLOGY | SECONDARY BACTERIAL PERITONITIS | CRITICALLY-ILL PATIENTS | INVASIVE CANDIDIASIS
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 8/2012, Volume 38, Issue 8, pp. 1272 - 1279
Candida spp. airway colonization could promote development of ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, a potentially... 
Candida spp | Multidrug-resistant | Pediatrics | Pain Medicine | Ventilator-associated pneumonia | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Anesthesiology | MORTALITY | RESPIRATORY-TRACT | BIOFILMS | PULMONARY INFECTION SCORE | INTENSIVE-CARE-UNIT | ANTIFUNGAL TREATMENT | ALBICANS | CRITICALLY-ILL PATIENTS | EXPRESSION | INVASIVE CANDIDIASIS | CRITICAL CARE MEDICINE | Pneumonia, Ventilator-Associated - mortality | Intensive Care Units | Pseudomonas aeruginosa - isolation & purification | Prospective Studies | Age Factors | Pseudomonas Infections - drug therapy | Humans | Middle Aged | Risk Factors | Male | Pseudomonas Infections - mortality | Candida - isolation & purification | Anti-Bacterial Agents - therapeutic use | Respiratory Mucosa - microbiology | Pneumonia, Ventilator-Associated - microbiology | Time Factors | Drug Resistance, Multiple, Bacterial | Female | Respiratory Mucosa - secretion | Pneumonia, Ventilator-Associated - drug therapy | Pneumonia | Antibiotics | Candida | Bacterial pneumonia | Physiological aspects | Development and progression | Health aspects | Airway (Medicine) | Index Medicus | Respiratory tract | Intensive care units | Pathogens | Hospitals | Mortality | Antibiotic resistance | ventilator-associated pneumonia | Drug resistance | Secretions | Colonization | Risk factors
Journal Article
Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 641 - 650
Journal Article
Journal Article